Efficacy and safety of peripheral blood stem cell mobilization and collection: A single-center experience in 190 allogeneic donors

Transfusion

Volumn 52, Issue 11, 2012, Pages 2387-2394

  Rinaldi, Cristina ^a   Savignano, Chiara ^a   Pasca, Samantha ^a   Sperotto, Alessandra ^a   Patriarca, Francesca ^a   Isola, Miriam ^a   Fanin, Renato ^a   De Angelis, Vincenzo ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGE; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BREAST CANCER; CD34 SELECTION; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COLON CANCER; DEEP VEIN THROMBOSIS; DONOR SELECTION; EPSTEIN BARR VIRUS INFECTION; FEMALE; FOLLOW UP; GENDER; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; LIVING DONOR; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MONOCLONAL IMMUNOGLOBULINEMIA; RETROSPECTIVE STUDY; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; STEM CELL MOBILIZATION; THROMBOEMBOLISM; THYROID CANCER; UNRELATED DONORS;

ADOLESCENT; ADULT; AGED; BLOOD DONORS; BLOOD SAFETY; FEMALE; FOLLOW-UP STUDIES; GRAFT VS LEUKEMIA EFFECT; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ITALY; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84869225263     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03619.x     Document Type: Article

References (25)

1. Baldomero H, Gratwohl M, Gratwohl A, Tichelli A, Niederwieser D, Madrigal A, Frauendorfer K,; for the European Group for Blood and Marrow Transplantation EBMT. The EBMT activity survey 2009: trend over the past 5 years. Bone Marrow Transplant 2011; 46: 485-501.
2. Gratwohl A, Baldomero H,. Trend of hematopoietic stem cell transplantation in third millennium. Curr Opin Hematol 2009; 16: 420-6.
3. Rhodes B, Anderlini P,. Allogeneic peripheral blood stem cell collection as of 2008. Transfus Apher Sci 2008; 38: 219-27.
4. Lysak D, Koristek Z, Gasova Z, Skoumalová I, Jindra P,. Efficacy and safety of peripheral blood cell collection in elderly donors; does age interfere? J Clin Apher 2010; 26: 9-16.
5. Al-Ali HK, Burgeois M, Krahl R, Edel E, Leiblein S, Poenisch W, Basara N, Lange T, Niederwieser D,. The impact of the age of HLA-identical siblings on mobilization and collection of PBSCs for allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2010; 6: 1-7.
6. Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL,. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from National Marrow Donor Program. Blood 2009; 113: 3604-11.
7. Siddiq S, Pamphilon D, Brunskill S, Doree C, Hyde C, Stanworth S,. Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors. Cochrane Database Syst Rev 2009;(1):CD006406.
8. Miller JP, Perry EH, Price TH, Bolan CD Jr, Karanes C, Boyd TM, Chitphakdithai P, King RJ,. Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donors Program. Biol Blood Marrow Transplant 2008; 14 Suppl: 29-36.
9. Holig K, Kramer M, Kroschinsky F, Bornhäuser M, Mengling T, Schmidt AH, Rutt C, Ehninger G,. Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood 2009; 114: 3757-63.
10. Halter J, Kodera Y, Ispizua AU, Greinix HT, Schmitz N, Favre G, Baldomero H, Niederwieser D, Apperley JF, Gratwohl A,. Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica 2009; 94: 94-101.
11. Anderlini P,. Effects and safety of granulocyte colony-stimulating factor in healthy volunteers. Curr Opin Hematol 2009; 16: 35-40.
12. Anderlini P, Przepiorka D, Seong D, Miller P, Sundberg J, Lichtiger B, Norfleet F, Chan KW, Champlin R, Körbling M,. Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobizilation and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion 1996; 36: 590-95.
13. Anderlini P, Przepiorka D, Champlin R, Körbling M,. Biologic and clinical effects of granulocyte-colony stimulating factor normal individuals. Blood 1996; 88: 2819-25.
14. Vasu S, Leitman SF, Tisdale JF, Hsieh MM, Childs RW, Barrett AJ, Fowler DH, Bishop MR, Kang EM, Malech HL, Dunbar CE, Khuu HM, Wesley R, Yau YY, Bolan CD,. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood 2008; 112: 2092-100.
15. Wang TF, Wen SH, Chen RL, Lu CJ, Zheng YJ, Yang SH, Chu SC, Kao RH, Chen SH,. Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings. Biol Blood Marrow Transplant 2008; 14: 1305-11.
16. Richa E, Papari M, Allen JA, Martinez G, Wickrema A, Anastasi J, Van Besien K, Artz A,. Older age but not donor health impairs allogeneic granulocyte colony-stimulating factor (G-CSF) peripheral blood stem cell mobilization. Biol Blood Marrow Transplant 2009; 15: 1394-9.
17. de la Rubia J, Lorenzo JI, Torrebadella M, Marín P, Insunza A, Sanz MA,. Basal CD34+ cell count predicts peripheral blood progenitor cell mobilization and collection in healthy donors after administration of granulocyte colony-stimulating factor. Haematologica 2004; 89: 1530-2.
18. Brown RA, Adkins D, Goodnough LT, Haug JS, Todd G, Wehde M, Hendricks D, Ehlenbeck C, Laub L, DiPersio J,. Factors that influence the collection and engraftment of allogenic peripheral-blood stem cells in patients with hematological malignancies. J Clin Oncol 1997; 15: 3067-74.
19. de la Rubia J, de Arriba F, Arbona C, Pascual MJ, Zamora C, Insunza A, Martínez D, Paniagua C, Díaz MA, Sanz MA,. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry. Haematolgica 2008; 93: 735-40.
20. Lysák D, Koza V, Jindra P,. Factors affecting PBSC mobilization and collection in healthy donors. Transfus Apher Sci 2005; 33: 275-83.
21. Martino M, Cllea I, Condemi A, Dattola A, Irrera G, Marcuccio D, Messina G, Pontari A, Pucci G, Console G, Lacopino P,. Predictive factors that affect the mobilization of CD34+ cells in healthy donors treated with recombinant granulocyte colony-stimulating factor (G-CSF). J Clin Apher 2006; 26: 169-75.
22. Martino M, Console G, Dattola A, Callea I, Messina G, Moscato T, Massara E, Irrera G, Fedele R, Gervasi A, Bresolin G, Iacopino P,. Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience. Bone Marrow Transplant 2009; 44: 163-8.
23. Leitner GC, Baumartner K, Kahls P, Biener D, Greinix HT, Hoecker P, Worel N,. Regeneration, health status and quality of life after rhG-CSF-stimulated stem cell collection in healthy donors: a cross-sectional study. Bone Marrow Transplant 2009; 43: 357-63.
24. Tassi C, Razzari PL, Bonifazi F, Giudice V, Nannetti A, Ricci F, Rizzi S, Bandini G, Conte R,. Short and long-term haematological surveillance of healthy donors allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study. Bone Marrow Transplant 2005; 36: 289-94.
25. Anderlini P, Champlin RE,. Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges. Blood 2008; 111: 1767-72.